Back
argenx SE Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
65
ARGX
argenx SE
Last Price:
587.98
Seasonality Move:
43.78%
Sell
36
PRQR
ProQR Therapeutics NV
Last Price:
3.63
Seasonality Move:
22.55%
Buy
65
argenx SE (ARGX)
is a Buy
Is argenx SE a Buy, Sell or Hold?
- The current argenx SE [ARGX] share price is $595.58. The Score for ARGX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- ARGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.73. The Score for PRQR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARGX Stock Price Chart
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRQR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.16 | Buy |
| Relative Strength Index (14 RSI): | 69.8 | Buy |
| Chaikin Money Flow: | -208079 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (530.8 - 566.12) | Buy |
| Bollinger Bands (100): | (451.67 - 553.61) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 64.96 | Buy |
| Chaikin Money Flow: | 280663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 3.67) | Buy |
| Bollinger Bands (100): | (1.45 - 2.69) | Buy |
ARGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 563.24 | Buy |
| 20-day SMA: | 549.65 | Buy |
| 50-day SMA: | 538.99 | Buy |
| 200-day SMA: | 442.32 | Buy |
| 8-day EMA: | 568.2 | Buy |
| 20-day EMA: | 555.52 | Buy |
| 50-day EMA: | 536.71 | Buy |
| 200-day EMA: | 473.51 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.51 | Buy |
| 20-day SMA: | 2.96 | Buy |
| 50-day SMA: | 2.31 | Buy |
| 200-day SMA: | 2.07 | Buy |
| 8-day EMA: | 3.51 | Buy |
| 20-day EMA: | 3.09 | Buy |
| 50-day EMA: | 2.55 | Buy |
| 200-day EMA: | 2.1 | Buy |
argenx SE Earnings Growth & ARGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.59 per share, and an increase next year of $6.80 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
argenx SE Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||